Free Trial

Organon & Co. (OGN) Earnings Date, Estimates & Call Transcripts

Organon & Co. logo
$8.72 -0.87 (-9.02%)
Closing price 05/5/2025 03:59 PM Eastern
Extended Trading
$8.70 -0.03 (-0.29%)
As of 05:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Organon & Co. Earnings Summary

Latest Q1
Earnings Date
May. 1Estimated
Consensus EPS
(May. 1)
$0.89
Actual EPS
(May. 1)
$1.02 Beat By $0.13
Actual Revenue
(May. 1)
$1.51B

Organon & Co. posted Q1 2025 earnings on May 1, 2025, reporting an EPS of $1.02, which beat the consensus estimate of $0.89 by $0.13. Quarterly revenue fell 6.7% year-over-year to $1.51 billion, below analyst estimates of $1.53 billion. With a trailing EPS of $2.88 and a P/E Ratio of 2.62, Organon & Co.'s earnings are expected to grow 1.63% next year, from $3.68 to $3.74 per share.

Q1 2025 Earnings Resources

Get Organon & Co. Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organon & Co. and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

OGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

OGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Organon & Co. Analyst EPS Estimates

Current Year EPS Consensus Estimate
$3.68 EPS
Next Year EPS Consensus Estimate
$3.74 EPS

Organon & Co. Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/1/2025Q1 2025$0.89$1.02+$0.13$0.33$1.53B$1.51B
2/13/2025Q4 2024$0.92$0.83 -$0.09$0.42$1.57B$1.59B
10/31/2024Q3 2024$0.90$0.87 -$0.03$0.24$1.56B$1.58B
8/6/2024Q2 2024$1.08$1.12+$0.04$1.31$1.61B$1.61B
5/2/2024Q1 2024$0.83$1.14+$0.31$1.50$1.57B$1.62B
2/15/2024Q4 2023$0.73$0.87+$0.14-$0.39$1.55B$1.60B
11/2/2023Q3 2023$1.04$0.78 -$0.26$1.33$1.59B$1.52B
8/8/2023Q2 2023$0.97$1.31+$0.34$1.67$1.57B$1.61B

Organon & Co. Earnings - Frequently Asked Questions

Organon & Co. (NYSE:OGN) last announced its quarterly earning data on Thursday, May 1, 2025. Learn more on OGN's earnings history.

Organon & Co. issued an update on its FY 2025 earnings guidance on Thursday, May, 1st. The company issued revenue guidance of $6.1 billion-$6.3 billion, compared to the consensus revenue estimate of $6.3 billion.

In the previous quarter, Organon & Co. (NYSE:OGN) reported $1.02 earnings per share (EPS) to beat the analysts' consensus estimate of $0.89 by $0.13. Learn more on analysts' earnings estimate vs. OGN's actual earnings.

The conference call for Organon & Co.'s latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Organon & Co.'s latest earnings report can be read online.
Read Transcript

Organon & Co.'s earnings report can be found in their filing with the SEC.
View SEC filing

Organon & Co. (NYSE:OGN) has a recorded annual revenue of $6.29 billion.

Organon & Co. (NYSE:OGN) has a recorded net income of $864 million. OGN has generated $2.88 earnings per share over the last four quarters.

Organon & Co. (NYSE:OGN) has a trailing price-to-earnings ratio of 2.62 and a forward price-to-earnings ratio of 2.37. The price/earnings-to-growth ratio is 0.9.

Organon & Co.'s earnings are expected to grow from $3.68 per share to $3.74 per share in the next year, which is a 1.63% increase.

More Earnings Resources from MarketBeat



This page (NYSE:OGN) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners